The outcomes confirmed a significant elevation in PLA2G16 expression in the gemcitabine-resistant cells relative to their parental counterparts (Figs. 3B and 3C), thereby suggesting a substantive association of PLA2G16 with gemcitabine resistance in pancreatic cancer. Here, PLAAT3 is linked to familial pancreatic carcinoma.